Denmark becomes first country in Europe to ditch AstraZeneca vaccine
Denmark has announced that it is abandoning the AstraZeneca vaccine, the first European country to do so, amid concerns about very rare but serious blood clots. The rollout of the vaccine has run into problems in several countries, with its use either temporarily suspended or restricted to older age groups.
When concerns first arose over the vaccine’s rare side-effects, Denmark was the first country in Europe to suspend its use. In Thailand, use of the vaccine was suspended last month, before officials judged it safe to proceed, with Health Minister Anutin Charnvirakul going on to confirm it would become the Kingdom’s primary Covid-19 vaccine.
Both the European drugs regulator and the World Health Organisation are standing by the jab, saying the benefits outweigh the risks. However, health officials in Denmark have now decided to ditch it for good.
“Denmark’s vaccination campaign will go ahead without the AstraZeneca vaccine.”
Denmark has reported 2 cases of thrombosis (blood clotting) linked to administration of the AstraZeneca vaccine, one of which proved fatal. The blood clot incidents arose after 140,000 people had received the jab. The Bangkok Post reports that 8% of Denmark’s 5.8 million inhabitants have been fully vaccinated and 17% have received their first dose.
The country plans to continue its rollout using the Modern and Pfizer-BioNTech vaccines. Officials say they are confident that the availability of other jabs, coupled with the fact that Covid-19 is relatively under control in Denmark, means the country’s mass inoculation can continue without issue.
Meanwhile, AstraZeneca has released a statement acknowledging the decision taken by Danish health authorities.
“We recognise and respect the decision taken by the Danish Health Authority. Implementation and rollout of the vaccine programme is a matter for each country to decide, based on local conditions. We will continue to collaborate with the regulators and local authorities to provide all available data to inform their decisions.”
SOURCE: Euro News | Bangkok Post
